Frequent Pediatric Antibiotics May Increase Asthma, Allergy Risks
Repeated antibiotic use before age 2 is associated with a higher risk for asthma, food allergies and hay fever later in life.
Tag: rhinitis
All
Latest
Frequent Pediatric Antibiotics May Increase Asthma, Allergy Risks
Repeated antibiotic use before age 2 is associated with a higher risk for asthma, food allergies and hay fever later in life.
Read More
Neuromark Chronic Rhinitis Treatment Shows Improvements at Six Months
The radiofrequency ablation treatment indicated for chronic rhinitis led to significant improvements in rhinitis, as well as ear symptoms, at six-month follow-up.
Read More
Sound Therapy Wearable FDA-Authorized for Nasal Congestion Relief
The over-the-counter device is FDA De Novo-authorized for at-home use to treat nasal congestion due to allergic and non-allergic rhinitis.
Read More
RhinAer Yields Lasting Relief for Chronic Rhinitis After One Treatment
Results of the RHINTRAC randomized controlled trial published in the International Forum of...
Read More
RhinAer Effective for Chronic Rhinitis After Two Years, Study Finds
A clinical trial has shown that patients with chronic rhinitis experienced sustained symptom relief and improved quality of life for up to two years following treatment.
Read More
CMS Assigns CPT Code to Chronic Rhinitis Treatment
The Centers for Medicare and Medicaid Services (CMS) recently assigned a CPT reimbursement code for the Neuromark System, Neurent Medical’s chronic rhinitis treatment.
Read More
Chronic Rhinitis Treatment Offers Significant Symptom Improvements
Chronic rhinitis patients treated with the Neuromark System demonstrated significant improvement in rhinorrhea and nasal congestion symptoms at 3 months, according to new data.
Read More
Neurent Medical Releases Chronic Rhinitis Treatment
Neurent Medical’s Neuromark Rhinitis Neurolysis Therapy (RNT) is now commercially available in limited US markets, the company reports.
Read More
AMA Establishes New CPT Code for Chronic Rhinitis Treatment Method
The American Medical Association Current Procedural Terminology (CPT) Editorial Panel accepted the application for a new Category I CPT code to report endoscopic destruction of the posterior nasal nerve using radiofrequency (RF) ablation, according to Aerin Medical Inc.
Read More
FDA Clears the Olympus Celeris Single-Use Sinus Debrider
The Olympus Celeris system contains the only single-use sinus debrider on the market and is indicated for cutting, coagulation, debriding and removal of thin bone and soft tissue in general ENT and sinus/rhinology procedures.
Read More
FDA Clears Neuromark Nerve Disruption Treatment for Chronic Rhinitis
The FDA has cleared the Neuromark Rhinitis Neurolysis Therapy (RNT), an in-office treatment designed to create lesions to disrupt the posterior nasal nerves, for patients with chronic rhinitis, according to Neurent Medical.
Read MoreGreater Risk of Asthma, Rhinitis with Exposure to Mold and Dampness
There is an increased risk of asthma and rhinitis for children up to 16 years of age when they are exposed to mold and dampness during infancy.
Read MoreAntibiotic Use, Mold Exposure in Infancy Increased Risk for Allergic Rhinitis
Adolescents exposed to antibiotic use and mold exposure during infancy had an increased risk for developing allergic rhinitis, according to recent study results.
Read MoreNew Seasonal and Perennial Rhinitis Intranasal Treatment Submitted for US and European Marketing Approval
GlaxoSmithKline (GSK), Research Triangle Park, NC, announced it has submitted applications for both US and European marketing approval for a new medicine to treat the symptoms of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR).
Read More